Top Markets
#1 Pleasing Gold Pleasing Gold +601.59%
#2 Islamic Coin Islamic Coin +154.12%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +41.48%
#5 DogBull DogBull +36.81%
#6 Neiro Neiro +24.76%
#7 Nockchain Nockchain +22.48%
#8 ORDI ORDI +19.01%
#9 SkyAI SkyAI +16.82%
#10 Monad Monad +16.62%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
BiOptic Inc. BiOptic Inc.

BiOptic Inc.

6850
Rank in Stocks #27135
BiOptic Inc. specializes as a biotechnology instrumentation firm, crafting... BiOptic Inc. specializes as a biotechnology instrumentation firm, crafting scientific tools designed for both laboratory research and clinical applications. Their extensive product line features various instruments, including sophisticated bio-fragment analyzers and PCR thermocyclers. Additionally, they supply essential consumables such as cartridges for DNA, RNA, and protein analysis, alongside quantification kits. The company further provides specialized PCR reagents, encompassing premixed formulas and polymerases. Completing their offerings are diverse diagnostic kits tailored for veterinary, human, and food-related testing. Founded in 1993, BiOptic Inc. is headquartered in New Taipei City, Taiwan.
Share Price
$1.05
Market Cap
$34.88M
Change (1 day)
-0.60%
Change (1 year)
-31.91%
Country
TW
Trade BiOptic Inc. (6850)

Category

Healthcare
Revenue for BiOptic Inc. (6850)
Revenue in Aug 2026 TTM: 0
According to BiOptic Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BiOptic Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH